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ABSTRACT
Background: Surgical clipping or
endovascular coiling are the main
procedures used in the treatment of cerebral
aneurysms, with a preference for
endovascular coiling. In Morocco, the
number of patients needing endovascular
coiling is growing, but many of them do
not have access to this technique. The aim of
this study was to determine the main
parameters associated with variations in the
total cost of this procedure in order to
establish the amount (lump sum) that may
be reimbursed by health insurance funds.
Methods: One hundred and seventeen patients
with 124 aneurysms were admitted for
treatment of one or more intracranial
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aneurysms between January 2010 and
December 2015. The overall cost of
hospitalization was assessed by using the
micro-costing technique. The calculation was
based on the tariffs of medical procedures as
defined by the Ministry of Health in Morocco. A
regression analysis was used to define the
correlation between the overall cost and the
various parameters.
Results: Univariate linear regression showed
that the total cost was influenced by overall
duration of hospitalization, ICU duration of
hospitalization and size of aneurysm. On the
other hand, univariate linear regression
showed that the total cost was not
influenced by sex, localization of aneurysm,
and size of the aneurysm’s neck. However,
multivariate linear regression showed that
the total cost was influenced by one type of
insurance health, overall duration of
hospitalization, ICU duration of
hospitalization, size of the aneurysm, and
size of the aneurysm’s neck.
Conclusion: Setting a rate for reimbursement of
patients who have had coiling treatment for a
cerebral aneurysm should take into account the
results of our study in order to limit the costs
borne by patients. The parameters that
influence the overall cost must be reimbursed
in each case while the parameters that do not
influence treatment costs could be included in a
lump sum.
Keywords: Aneurysm embolization;
Endovascular coil; Health insurance;
Micro-costing; Reimbursement
BACKGROUND
Aneurysmal subarachnoid hemorrhage (aSAH)
is a significant cause of morbidity and mortality
throughout the world [1]. Aneurismal rupture,
accompanied by a SAH, is associated with a
mortality of 30–67% and a morbidity of 15–30%
[2, 3]. The overall prevalence of intracranial
aneurysm is between 0.5 % and 6 % of the total
population, based on angiographic study or
autopsy [4, 5]. These account for about 80–85 %
of non-traumatic subarachnoid hemorrhages
[6]. There are two options for treating cerebral
aneurysms, neurosurgical treatment with
clipping of the malformation and
neuroradiology treatment (embolization) to
occlude the malformation via an endovascular
procedure. The proportion of patients treated
with microsurgery has decreased in the last two
decades, especially in the elderly in whom
embolization should strongly be considered as
a first-line treatment for cerebral aneurysms [7].
This phenomenon has increased since the
publication of the International Subarachnoid
Aneurysm Trial (ISAT) study in 2002 [8].
The ISAT is the first multicenter prospective
randomized trial comparing endovascular
treatment and surgery [8]. A total of 2,143
patients with ruptured intracranial aneurysms
were randomly assigned to clipping (n = 1070)
or coiling (n = 1073). The ISAT trial demonstrated
that in patients with ruptured intracranial
aneurysms suitable for both treatments,
endovascular coiling is more likely to result in
independent survival at 1 year thanneurosurgical
clipping; this survivalbenefitcontinues forat least
7 years. The risk of late rebleeding is low, but is
more common after endovascular coiling than
after neurosurgical clipping [9].
New and innovative procedures, such as
cerebral aneurysm coiling, can be associated
with significant cost and will be in the spotlight
in this changing landscape [10]. The average
cost of endovascular treatment differs from one
country to another. In the USA, two studies
were conducted on a predictive model of the
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cost of hospitalization after cerebral aneurysm
coiling and cerebral aneurysm clipping [10, 11].
They concluded that the median
hospitalization cost was US$35,446 (31,192 €)
and US$69,304 (60,988 €) for unruptured and
ruptured aneurysms, respectively, after cerebral
aneurysm coiling [10]. In France, it was assessed
as 14,477.39 € [12]. In Pakistan, the average cost
of endovascular treatment was estimated at €
5080 [13].
In our hospital, the overall average cost of
treatment using the embolization technique
was assessed to be 9697.8 € 14; a large
proportion of this amount is paid by the
patients because the fee paid by Mandatory
Health Insurance regimen is only 5364 €.
Currently, the fee paid by the health insurance
funds is the same whatever the clinical
parameters of the patients (number of
aneurysm, aneurysm size, size of the aneurysm
neck, number of hospital days, number of
devices used, etc.).
No study to date in Morocco has explored
the clinical parameters associated with the
change in cost of treatment of cerebral
aneurysms by embolization. Such a study
could be used to redefine the lump sum
refunded by health insurance and minimize
the fees paid by patients. This co-payment can
be catastrophic in certain situations.
Our aim was to study the parameters that
influence the overall cost of treatment of
cerebral aneurysm embolization care in order
to take them into account in the definition of
the lump sum to be reimbursed for this
technique by health insurance funds.
METHODS
One hundred and seventeen patients who
underwent endovascular treatment of one or
more intracranial aneurysms were followed
between January 2010 and October 2015. The
cost was assessed by using the micro-costing
method that takes into account all direct costs
(hospitalization, physician services, visits,
clinical investigations, and medications). The
total cost was estimated by adding up the
money spent by patients for treatment
modality. The costs of different services were
collected from the hospital billing system. It
included data on all expenses incurred by
patients during hospitalization. All costs are
presented in Euros (1 Euro = 11 Moroccan
Dirhams (MAD)). The cost of treatment
reported in this article does not include
expenditure on additional hospitalization in
another institution after discharge,
rehabilitation in any institution other than
Cheikh Zaid Hospital, or any anticipated
expenditure regarding future procedures.
The parameters that could influence the
overall cost of care for the treatment of
intracranial aneurysm by embolization and
that we studied were: Age, sex, type of
insurance health coverage, origin, time
between hospital admission and the onset of
symptoms, overall length of stay, intensive care
unit (ICU) length of stay, admission pattern,
glasgow coma scale score, localization of the
aneurysm, number of the aneurysm, size of the
aneurysm, and size of the aneurysm’s neck.
Statistical analyses were performed using
SPSS 13.0 for Microsoft Windows XP software.
Distributed continuous variables were expressed
as means ± standard deviations or as median
and interquartile ranges. Qualitative variables
were expressed as number and frequencies. The
correlation between cost and other qualitative
and quantitative parameters was established
with the Spearman and Mann-Whitney tests.
The Kruskal-Wallis test was used for comparing
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between-group costs. The variables associated
with the cost were studied by univariate and
multivariate linear regression. The variables that
were associated statistically significantly with
costs or had a p value less than 0.3 in the
univariate analysis were used in the
multivariate analysis. The level of significance
was fixed at 5 %.
This article does not contain any new studies
on human or animal subjects performed by any
of the authors.
RESULTS
A description of the clinical parameters of the
patients in our study is presented in Table 1
below.
In total, 124 aneurysms in 117 patients were
treated. The mean age of the patients was
51.2 ± 14 years. Fifty-one (43.6 %) patients
were men and 66 (56.4 %) were women. The sex
ratio was M/F = 0.43. Seventy (60 %) patients
were covered by health insurance. The median
overall stay was 7 days (range 4–11), 1 day in the
ICU (1–2) and 5 days in medical units (2.5–9).
The overall average cost of treatment was
9606.0 €, varying from 3,702.3 € to 32,172.3 €.
Pharmaceutical products represent 55 % of the
overall cost (70 % for medical devices and 30 %
for drugs) and the average was 5280.5 € with a
range of 2087.4 €–19,526.2 €.
Univariate linear regression showed that the
total cost was influenced by overall duration of
hospitalization, ICU duration of
hospitalization, size of aneurysm. On the other
hand, univariate linear regression showed that
the total cost was not influenced by sex,
localization of the aneurysm, and size of
aneurysm’s neck (Table 2).
However, multivariate linear regression
showed that the total cost was influenced by
Table 1 Clinical parameters of 117 patients treated by
embolization
Patient characteristics Number
(%)
Health insurance
National Fund for public salaries
(CNOPS)
40 (34.2)
National Fund for private salaries (CNSS) 4 (3.4)
Out of pocket 47 (40.2)
Private fund for private salaries 26 (22.2)
Tobacco
Yes 38 (32.5)
No 79 (67.5)
Arterial hypertension
Yes 28 (23.9)
No 89 (76.1)
Admission causes
Sub-arachnoid hemorrhage 91 (77.8)
Ophthalmological disorders 13 (11.1)
Recovery (recanalization) 7 (6.0)
Fortuitous 4 (3.4)
Iatrogenic 2 (1.7)
Distance from the hospital
Radius B100 km 45 (38.5)
100 km\radius B 200 km 16 (13.7)
Radius[200 km 26 (22.2)
Foreigners 15 (12.8)
Undeﬁned 15 (12.8)
Admission after symptoms
Less than 48 h 24 (20.5)
Between 48 h and 7 days 28 (23.9)
Between 7 and 30 days 30 (25.6)
Over 30 days 7 (6.0)
Recovery 9 (7.7)
Imprecise 19 (16.3)
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one type of health insurance, overall duration
of hospitalization, ICU duration of
hospitalization, size of aneurysm, and size of
the aneurysm’s neck (Table 2).
DISCUSSION
Our sample is considered one of two large series
of intracranial aneurysm treatments using
embolization in Morocco. This series is the
only series that has been published and that
sets out all expenses related to the care of
patients within the hospital. This was achieved
with the availability of an integrated hospital
information system that reports all expenses
related to patient care.
Almost all the studiespublishedhavecompared
the cost of coiling and clipping of ruptured
intracranial aneurysms. All these studies originate
from developed countries where medical
insurance covers most of the medical expenses,
andwhere theper capita income ishigher than the
world average [15]. They concluded that while the
endovascular procedure tended to be more
expensive in terms of cost of consumables, this
expensewasmore than compensated by savings in
staffing costs, and the period and cost of
hospitalization [13, 16–19].
Johnston et al. concluded that total length of
staywas longer (mean 7 days for surgical patients
vs. 5 days for endovascular patients) andhospital
charges were greater for surgical clipping (US$
38,000 for surgical patients vs. US$33,400 for
endovascular patients) [20]. Duan et al.
(Cleveland, OH, USA) concluded that morbidity
and length of stay for patients treated with
clipping was greater. Total hospital costs and
variable direct costs for clipping were
significantly lower than for coiling (p = 0.003,
p\0.001, respectively). Fixed direct costs and
fixed indirect costs for clipping were higher than
for coiling (p\0.001, p\0.001, respectively).
Variable direct costs comprised 50.5 % and 68.6
% of total hospital costs for clipping and coiling,
respectively (p\0.001) [21].
Lad et al., however, concluded that although
the surgical clipping resulted in lower
reoperation rates, it was associated with higher
complication rates and initial costs. However,
overall costs at 2 and 5 years were similar to
endovascular coiling due to the significantly
higher number of follow-up angiograms and
outpatient costs in these patients [22].
Table 1 continued
Patient characteristics Number
(%)
Location
Anterior communicating 40 (34.2)
Middle cerebral artery 11 (9.4)
Para-ophthalmic 14 (12.0)
Intracranial carotid bifurcation 16 (13.7)
Posterior communicating 16 (13.7)
Posterior circulation 11 (9.4)
Intracavernous 7 (6.0)
Other location 2 (1.7)
WFNS grading scale
I 86 (73.5)
II 14 (12.0)
III 7 (6.0)
IV 10 (8.5)
Number of aneurysms
1 111 (94.9)
2 5 (4.2)
3 1 (0.9)
Ruptured or unruptured
Yes 91 (77.8)
No 26 (22.2)
WFNS World Federation of Neurosurgical Societies
Neurol Ther (2016) 5:145–154 149
Similarly, some observational studies of
patients with unruptured intracranial
aneurysms show that discharge outcomes were
better and hospital costs were lower after
endovascular treatment than after surgery.
These patients showed no difference between
the two treatments in 1-year outcomes and later
rebleeding, although few data were available for
this comparison [19, 23].
We performed this comparative study at
Cheikh Zaid hospital in Rabat and we found
similar results compared to the studies cited
above. Ninety patients were treated by
embolization and 13 patients by neurosurgery.
Table 2 Parameters related to changes in overall cost of treatment of cerebral aneurysm embolization: Univariate and
multivariate analysis (linear regression)
Independent variables Univariate analysis Multivariate analysis
b 95 % CI p b 95 % CI p value
Sex
Male 0 0
Female 1,921.0 -238.4 to 4,080.5 0.08 1,058.6 -106.1 to 2,223.3 0.07
Health insurance type
National Fund for
public salaries (CNOPS)
0 0
National Fund for private
salaries (CNSS)
-2916.8 -5,771.4 to 62.1 0.04 -516.9 2,026.6–992.8 0.5
Out of pocket -491.9 -6,213.8 to 5230.1 0.86 3744.3 665.4–6,823.1 0.01
Private fund for private salaries -3821.9 -6,457.2 to 1,186.7 0.04 -700.4 -2,160.4 to -759.6 0.34
Location of aneurysm
Anterior communicating 0 0
Middle cerebral artery -4965.3 -12,903.9 to 2,973.2 0.22 2703.8 -1,393.5 to 6,801.1 0.19
Para-ophthalmic -4244.5 -12,516.3 to 4,027.2 0.31 1857.2 -2,331.3 to 6,045.7 0.38
Intracranial carotid bifurcation -4622.4 -13,098.4 to 3,853.6 0.28 3279.4 -1,071.9 to 7,630.8 0.14
Posterior communicating -4116.2 -12,592.3 to 4,359.8 0.34 2740.8 -1,565.5 to 7,046.7 0.21
Posterior circulation -4386.9 -12,624.2 to 3,850.3 0.30 2762.4 -1,455.3 to 6,980.0 0.19
Intracavernous -5291.1 -13,702.7 to 3,120.5 0.22 1622.6 -2,727.9 to 5,973.2 0.46
Other location -7584.7 -17,061.2 to 1,891.8 0.12 -584.0 -5,519.9 to 4,351.8 0.81
Overall length of stay 363.3 283.6–4,43.1 \0.001 90.0 15.9–164.2 0.01
ICU length of stay 560.9 476.1–645.8 \0.001 497.5 398.9–596.0 \0.001
Size of aneurysm 246.7 43.6–449.9 0.017 211.4 58.3–364.4 0.007
Size of aneurysm’s neck 426.0 -38.2 to 890.2 0.07 388.2 34.0–742.4 0.03
CNOPS Caisse Nationale des Organismes de Pre´voyance Sociale, CNSS Caisse Nationale de Se´curite´ Sociale, ICU intensive
care unit
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The median overall length of stay was greater in
patients treated by neurosurgery (13 vs. 8 days,
respectively). By contrast, the median cost of
pharmaceutical products was more signifcant
for embolization than for neurosurgery (4,000 €
vs. 1,570 €, respectively). This difference was
offset by the cost of hospitalization which was
far more for patients treated with neurosurgery.
The difference in the average overall cost
between the two groups was not significant
(p = 0.39).
Furthermore, endovascular treatment can be
a good option for the treatment of cerebral
aneurysms in this context; it reduces the length
of hospital stay, and therefore avoids the risk of
complications or nosocomial infections. This
will also allow the hospital to admit more
patients. However, the high cost of
pharmaceutical products used in such a
procedure can impact heavily on the budget of
the hospital.
Our series concluded that the cost of
pharmaceutical products is one of the major
handicaps of the development of this
technique (the share of pharmaceutical
product cost is 55 % of the overall cost),
specifically coils, stents, balloons,
micro-catheters, and guides. In Morocco,
there is no regulation (pricing) of medical
devices by the ministry of health [14]. The
cost of medical devices is negotiated between
hospitals and suppliers after validation by the
committee on drugs and medical devices [14].
This is one of the factors contributing to the
high cost of medical devices used in this
technique. The fact that the cost of coils and
other medical devices is the main contributor
to the higher costs of coiling was also found in
the study by Duan et al. [21].
The second obstacle in improving this
technique is the balance of fees paid by health
insurance (5364 €), which is only 75 % of the
average full cost calculated in this series. The
remaining cost is borne by the patients.
Unfortunately, the lump sum as defined in
public hospitals and health insurance funds is
not always reimbursed by these funds.
Moreover, there is no agreement between
health insurance funds and the private sector
to support all expenses related to this
procedure.
This study shows that the lump sum paid or
reimbursed by the health insurance system
remains very low and does not encourage
health professionals and patients to use this
technique as much as possible. Health
insurance aims to improve patient access to
quality care while minimizing their
contribution and avoiding situations where
they may be faced with catastrophic expenses.
In the case of treatment with embolization, the
health insurance system has a strong interest in
encouraging use of this technique with minimal
charges for patients, by increasing the fees
allocated to this procedure to cover all
expenses especially pharmaceutical products,
which account for 55 % of the overall cost.
Therefore, to develop this technique in
Morocco, we suggest valuing the cost of the
technique and reducing co-payments incurred
by patients.
The results of our study show that it is very
difficult to allocate a lump sum to this
treatment because the overall cost of care
depends on several parameters that cannot be
standardized between patients. The results of
our study also show that the overall cost of care
is influenced by the total length of stay in
hospital and the length of stay in the ICU. This
result can be explained by the fact that if the
number of patient days increased, specifically in
the ICU, the overall cost of hospitalization
becomes important and significantly affects
the cost of global support.
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In addition, there is a significant correlation
between the global cost and the size of the
aneurysm on the one hand and the size of the
aneurysm’s neck on the other. These results are
logical because the larger the size of the
aneurysm, the greater the number of coils.
Also, the number and type of devices used are
related to the aneurysm’s neck size; the
neuroradiologist is forced to use a balloon
dilatation or stent, which involves a
significant increase in costs incurred.
Our study has some limitations, mainly
relating to the lack of data on the cost of
other services that the patient may have outside
the hospital, the cost of other services provided
post-embolization, and the amount actually
reimbursed by the health funds for each patient.
CONCLUSION
The coiling technique is an effective modality
for the treatment of intracranial aneurysms.
Unfortunately, this technique is expensive and
not available to all patients, especially those not
covered by a health insurance plan. In addition,
the co-payment that patients covered by the
compulsory health insurance scheme in
Morocco have to bear is significant, as the
package specified by the national health
insurance agency and insurance funds remains
below the actual value of the disease
management.
Setting a rate for reimbursement of patients
who have had coiling treatment of a cerebral
aneurysm should take into account the results
of our work in order to limit the amount borne
by patients. The parameters that influence the
overall cost must be reimbursed in each case
while the parameters that do not influence
treatment costs could be included in a package.
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